Syngene International Ltd

NSE : SYNGENE13 Jan 2025

Healthcare

₹

-37.05 (-4.31%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Syngene International Ltd

Syngene International Ltd

Healthcare

NSE : SYNGENE13 Jan 2025

₹

-37.05 (-4.31%)

OverviewFundamentalsFutures Options

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
24-Apr-2024	D	The Board of Directors recommends Final Dividend of Rs. 1.25/- per share.	28-Jun-2024
26-Apr-2023	D	Board approved:- 1. The Board recommended a final dividend of Re. 1.25/- per Equity Share of Rs. 10/-(comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.75 per share to mark the 30th anniversary of the founding of the Company in November 1993) subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The record date is fixed as Friday, June 30, 2023 for payment of dividend. The dividend will be paid within 30 days from the date of shareholders' approval. Annual General Meeting: 2. Cconvening of the 30th Annual General Meeting of the Company on Wednesday, July 26, 2023	30-Jun-2023
26-Apr-2023	D	Board approved:- 1. The Board recommended a final dividend of Re. 1.25/- per Equity Share of Rs. 10/-(comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.75 per share to mark the 30th anniversary of the founding of the Company in November 1993) subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The record date is fixed as Friday, June 30, 2023 for payment of dividend. The dividend will be paid within 30 days from the date of shareholders' approval. Annual General Meeting: 2. Cconvening of the 30th Annual General Meeting of the Company on Wednesday, July 26, 2023	30-Jun-2023
27-Apr-2022	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered and approved the following: Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.50 per share) for the Financial year March 31, 2022 subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days from the date of shareholders' approval at the ensuing Annual General Meeting.	30-Jun-2022
27-Apr-2022	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2022, inter alia, has considered and approved the following: Recommended final dividend of Re. 1/- per Equity Share of Rs. 10/- each of the Company (comprising a regular dividend of Re. 0.50 per share and a special additional dividend of Re. 0.50 per share) for the Financial year March 31, 2022 subject to shareholders' approval at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days from the date of shareholders' approval at the ensuing Annual General Meeting.	30-Jun-2022
25-Apr-2019	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 24, 2019, inter alia, has considered and approved the following: 1. Recommended final dividend at a rate of 5% i.e. Rs. 0.50 per equity share for the financial year ended March 31, 2019, subject to shareholders' approval at the ensuing Annual General Meeting and the dividend will be paid within 30 days from the date of shareholder's approval at the ensuing Annual General Meeting. Please find attached the Outcome of the Board Meeting held April 24, 2019. (As Per BSE Announcement Dated 24.04.2019)	16-Jul-2019
25-Apr-2018	D	Syngene International Ltd has informed BSE that the Board of Directors at its meeting held on April 25, 2018, inter alia, has considered and approved the following: - Recommended a final dividend at a rate of 10% i.e. Rs. 1.00 per equity share for the financial year ended March 31, 2018, subject to shareholders' approval at the ensuing Annual General Meeting.	17-Jul-2018
27-Apr-2017	D	Financials Results for the quarter and year ended March 31, 2017	20-Jul-2017
11-Mar-2016	D	Syngene International Ltd has informed BSE that the Board of Directors of the Company vide its circular resolution dated March 11, 2016 has approved the payment of Interim dividend at a rate of 10% i.e. (Re. 1/- per share) for the financial year 2015-16. The said Interim dividend, will be paid on March 29, 2016.	17-Mar-2016
30-May-2019	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Syngene International Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Syngene International Limited (539268) RECORD DATE 12.06.2019 PURPOSE Issue of 1 (One) Bonus equity share of Rs.10/- each for every 1 (One) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 11/06/2019 DR-049/2019-2020 Trading Members of the Exchange are requested to take of it. (As Per BSE Notice Dated on 07.06.2019)	12-Jun-2019	1:1
13-Jan-2025	BC	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve the un-audited standalone and consoli	23-Jan-2025
10-Dec-2024	BC	Biocon Ltd & PACs	10-Dec-2024
23-Oct-2024	BC	Outcome of the Board Meeting - October 23, 2024.	01-Dec-2024
23-Oct-2024	BC	Outcome of the Board Meeting - October 23, 2024.	30-Nov-2024
04-Oct-2024	BC	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the un-audited standalone and consoli	23-Oct-2024

Announcement Date24-Apr-2024

Ex Dividend Date28-Jun-2024

Dividend(%)12

Announcement Date26-Apr-2023

Ex Dividend Date30-Jun-2023

Dividend(%)5

Announcement Date26-Apr-2023

Ex Dividend Date30-Jun-2023

Dividend(%)8

Announcement Date27-Apr-2022

Ex Dividend Date30-Jun-2022

Dividend(%)5

Announcement Date27-Apr-2022

Ex Dividend Date30-Jun-2022

Dividend(%)5

Announcement Date25-Apr-2019

Ex Dividend Date16-Jul-2019

Dividend(%)5

Announcement Date25-Apr-2018

Ex Dividend Date17-Jul-2018

Dividend(%)10

Announcement Date27-Apr-2017

Ex Dividend Date20-Jul-2017

Dividend(%)10

Announcement Date11-Mar-2016

Ex Dividend Date17-Mar-2016

Dividend(%)10

No Rights has been declared by SYNGENE

Book Closure

Record Date	Split Date	Purpose
23-Jan-2025	-	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve the un-audited standalone and consoli
10-Dec-2024	-	Biocon Ltd & PACs
01-Dec-2024	-	Outcome of the Board Meeting - October 23, 2024.
30-Nov-2024	-	Outcome of the Board Meeting - October 23, 2024.
23-Oct-2024	-	Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the un-audited standalone and consoli

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Syngene International Ltd ₹822.75(-37.05/-4.31%)	822.75	-37.05	33,118.73	12.08	75.46	7.67
Poly Medicure Ltd ₹2,599.15(-76.80/-2.87%)	2,599.15	-76.80	26,336.07	78.88	90.30	10.22
Fortis Healthcare Ltd ₹662.75(-24.45/-3.56%)	662.75	-24.45	50,034.85	60.01	264.32	5.52
Indegene Ltd ₹603.35(-11.55/-1.88%)	603.35	-11.55	14,436.29	5.68	92.53	8.14
GPT Healthcare Ltd ₹167.03(-9.31/-5.28%)	167.03	-9.31	1,370.56	-12.91	27.97	5.94
Shalby Ltd ₹214.47(-8.31/-3.73%)	214.47	-8.31	2,316.49	-28.94	24.31	2.10

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	72.10	259.00	318.90	191.80	163.70
Net Cash from Operating Activities	913.40	838.40	582.20	698.00	677.40
Net Cash Used In Investing Activities	-382.60	-685.10	-610.80	-628.90	-423.80
Net Cash Used In Financing Activities	-536.30	-340.20	-31.30	58.00	-225.50
Net Inc./Dec In Cash And Cash Equivalents	-5.50	-186.90	-59.90	127.10	28.10
Cash And Cash Equivalents At End Of The Year	66.60	72.10	259.00	318.90	191.80

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

54.72%

FII Shareholding

20.72%

DII Shareholding

17.48%

Public Shareholding

6.74%

**Promoter pledged shareholding 54.72%

About Syngene International Ltd

Syngene International Ltd is in the Healthcare sector, having a market capitalization of Rs. 33140.87 crores. It has reported a sales of Rs. 821.3 crores and a net profit of Rs. 96.6 crores for the quarter ended December 2018. The company management includes Kiran Mazumdar Shaw, Kiran Mazumdar Shaw,Catherine Patricia Rosenberg,Paul Frederick Blackburn,Vijay Kuchroo,Jonathan Hunt,Vinita Bali,Priyadarshnini Mahapatra,Sharmila Karve,Kush Parmar,SIBAJI BISWAS,Nilanjan Roy,Manja Boerman (Syngene International Ltd) among others.

Chairman

Kiran Mazumdar Shaw

Registered office

Biocon SEZ Biocon Park,Plot No 2 & 3 Bommasandra Inds,Bengaluru,Karnataka,560099

FAX :91-80-28083189

Background

Incorporation Year1993

Face Value₹10

Market Lot1